New capital and leadership accelerate Subtle Medical’s mission to set a new standard for speed, quality, and patient experience in medical imaging

MENLO PARK, Calif., June 2, 2026 — Subtle Medical, a leading provider of AI-powered medical imaging software, today announced it has secured $33 million in growth capital, anchored by a Series C financing led by funds managed by Morgan Stanley Expansion Capital, and appointed medical imaging executive, Ohad Arazi, as Chief Executive Officer.

The financing included participation from Korea-based Shinhan Venture Investment and existing investors, Fusion Fund, EnvisionX, BRV, and Samsung Ventures, bringing the company’s total capital raised to $86 million. Subtle Medical will use the new capital to accelerate product development, expand commercial adoption globally, and scale its vendor-neutral AI imaging platform across MRI, PET, and CT workflows.

Medical imaging remains a bottleneck across health systems: exams can be lengthy, uncomfortable, and difficult to tolerate, particularly for pediatric, elderly, and critically ill patients. Longer scan times can reduce image quality, delay diagnosis, and limit scanner capacity. Subtle Medical addresses these challenges with AI software that improves image quality and accelerates scans on existing imaging systems, helping providers increase throughput without purchasing new hardware.

Founded by Enhao Gong, PhD, and Greg Zaharchuk, MD, PhD, Professor of Neuroradiology at Stanford University, Subtle Medical helped pioneer the category of AI-powered image enhancement in radiology. The company’s solutions support up to an 80% reduction in scan time and are deployed on more than 1,300 scanners across hospitals and imaging centers globally.

As part of its next phase of growth, the company has appointed industry veteran, Ohad Arazi, as CEO to accelerate global enterprise expansion. Arazi brings decades of experience in medical imaging AI, with CEO and leadership roles at Change Healthcare, Zebra Medical Vision, and most recently, Clarius Mobile Health. Enhao Gong, PhD, co-founder and former CEO of Subtle Medical, has transitioned to Chief Science Officer, where he will lead the company’s scientific roadmap and continue supporting operations and strategic partnerships in China.

“What drew me to Subtle is that this isn’t a point solution – it’s becoming the AI layer where health systems run their imaging,” said Ohad Arazi, Chief Executive Officer of Subtle Medical. “That’s a fundamentally different kind of company, and a bigger opportunity. I’ve spent my career at the intersection of imaging and enterprise software, and I haven’t seen many platforms with this combination of clinical validation and scalability. I’m here to make sure the world knows about it.”

“Subtle Medical solves a real operational problem for health systems: imaging backlogs that delay care and constrain capacity,” said Kevin Han, Executive Director at Morgan Stanley Expansion Capital. “We are excited to support Subtle Medical’s next phase of growth to help enhance the patient experience in medical imaging.”

Subtle’s flagship products, SubtleHD™(MR) and SubtlePET™, are deployed across major imaging networks, academic medical centers, and leading health systems worldwide. Customers including Mount Sinai, RadNet, and Radiology Partners have reported measurable gains in throughput, efficiency, and patient experience, establishing Subtle as an essential AI infrastructure layer for modern radiology.

At the center of this strategy is Subtle’s AI Imaging Hub, a unified platform that gives health systems a single point of control for imaging performance across scanners, regardless of manufacturer. Rather than managing AI tools scanner by scanner or modality by modality, providers can enhance image quality, standardize outputs, and streamline workflows across their entire infrastructure in real time. Unlike OEM-native AI, which is tied to specific equipment, or fragmented point solutions that address one modality at a time, the Hub operates across MRI, PET, and CT environments simultaneously, making it easier for health systems to scale AI adoption without adding complexity.

Subtle is also advancing AI-enabled contrast-enhanced imaging through the development of SubtleGAD™, a technology designed to enable significantly lower-dose gadolinium-enhanced MRI. Research has demonstrated the potential for up to a 90% reduction in gadolinium contrast dose while preserving diagnostic image quality, supporting the company’s vision for safer, more patient-centered imaging.

“Subtle Medical was founded to make advanced imaging faster, safer, and more accessible,” said Enhao Gong, PhD, co-founder and Chief Science Officer. “As we enter this next phase, I’m excited to welcome Ohad and continue advancing the science behind our platform while expanding its impact across global imaging workflows.”

About Subtle Medical, Inc.

Subtle Medical is a leading provider of AI-powered imaging solutions, optimizing scan efficiency and image quality across radiology. Recognized by TIME as a World’s Top Healthcare Company (2025), an Nvidia Inception Award winner, and multiple times as a CB Insights GenAI 50, Digital Health 150, and Top AI 100 company, Subtle Medical is committed to transforming medical imaging through responsible and intelligent software. The company’s solutions are deployed on over 1,300 scanners worldwide, helping imaging centers and hospitals deliver faster scans, improve image quality, and enhance patient care without the need for new hardware. Learn more at www.subtlemedical.com.

About Morgan Stanley Expansion Capital

Morgan Stanley Expansion Capital is the growth-focused private investment platform within Morgan Stanley Investment Management. Morgan Stanley Expansion Capital targets late-stage growth equity and credit investments within healthcare, technology, consumer and other high-growth sectors. For nearly four decades, Morgan Stanley Expansion Capital has successfully pursued growth investment opportunities and has completed investments in over 220 companies, leveraging the global brand and network of Morgan Stanley.

Media Contact:
Anna Menyhart-Borroni
Head of Global Marketing
[email protected]

SOURCE Subtle Medical, Inc.

GREENWICH, Conn., June 2, 2026 — Wingman Growth Partners (“Wingman”), an investment firm focused on software, data, and financial technology businesses, announced the closing of Wingman Growth Partners Fund I (“Wingman I” or the “Fund”). Wingman I was oversubscribed at its $215 million hard cap, exceeded its $150 million target by more than 40%, and closed in less than one year. The Fund received strong support from a diverse group of individual and institutional investors, including endowments, family offices, foundations, and funds of funds from North America and around the world.

Wingman’s mandate is intentionally narrow: a concentrated portfolio of six to eight platform investments, deep sector specialization in vertical and mission-critical software, and a hands-on operating model designed to drive measurable value creation across go-to-market efficiency, product, pricing, talent, and M&A. Wingman partners with founder-led, growth-stage technology companies with proprietary intellectual property and domain expertise that are well-positioned to harness AI to drive value for their customers.

“We are deeply grateful for the support of our investors. The demand for our inaugural fund, particularly in the current economic environment, reflects conviction in both our strategy and our team,” said Jeff Machlin, Wingman Founder and Managing Partner. “We believe strongly that mission-critical software is not only durable in the age of AI but attractively positioned to harness it to unlock additional value for customers.”

Wingman’s team has over 50 years of combined experience investing in and advising software companies through major growth transformations. The team includes seasoned investment professionals, operators, and advisors with experience at blue-chip private equity firms and category-defining software companies.

In January, the firm announced its investment in InterProse, a leading provider of cloud-native software for the accounts receivable management industry, followed by the acquisition of Beam Software, uniting two purpose-built technology collections platforms to create a well-positioned industry leader.

Kirkland & Ellis LLP served as legal advisor for Wingman I. Strathmore Group served as placement agent.

About Wingman Growth Partners

Wingman is a private investment firm focused on software, data, and financial technology businesses. The firm partners with founder-led, growth-stage companies with deep intellectual property and domain expertise, providing capital, strategic support, and operational expertise to help them scale and win in their markets. Learn more at www.wingmangrowth.com.

SOURCE Wingman Growth Partners

LAGUNA BEACH, Calif., June 2, 2026 — Tavo Biotherapeutics today announced the successful closing of a $17 million Series A financing led by Pureos Bioventures with participation by Polaris Partners and continued support from existing investor Tau Capital. The proceeds will be used to advance Tavo’s pipeline of innovative therapies targeting glaucoma and retinal disease.

In conjunction with the financing, Tavo Biotherapeutics also announced the appointment of Federico Grossi, M.D., Ph.D., as Chief Medical Officer, to lead the company’s clinical development strategy and execution. Previously, Dr. Grossi was Chief Medical Officer of Apellis Pharmaceuticals, where he led clinical development for two groundbreaking FDA-approved therapies: Syfovre for geographic atrophy and Empaveli for paroxysmal nocturnal hemoglobinuria (PNH).

In addition, Tavo announced that Daniel Bradbury has joined the Board of Directors as Chairman. Mr. Bradbury is a life sciences executive with over 40 years of experience creating and implementing strategies to bring novel medicines to market. Mr. Bradbury is the former Chief Executive Officer of Amylin Pharmaceuticals, a biopharmaceutical company that launched three first-in-class medicines focused on metabolic diseases before its acquisition by Bristol-Myers Squibb Company in 2012.

In conjunction with the financing, Dominik Escher, Ph.D. and Nil Gural, Ph.D., have joined Tavo’s Board of Directors representing Pureos Bioventures and Polaris Partners, respectively, bringing deep expertise in company building, financing, and the development of innovative therapeutics.

“We are thrilled to partner with Pureos and Polaris, and we are grateful for the continued support of Tau Capital,” said Gary Berman, Chief Executive Officer of Tavo Biotherapeutics. “This financing enables us to accelerate the advancement of our programs in glaucoma and retinal disease, where there remains a critical need for new, more effective treatment options. We are also excited to welcome Fede to the team. His deep clinical and development experience will be invaluable as we advance our pipeline.”

“Tavo has built a compelling pipeline addressing major unmet needs in ophthalmology with differentiated science and a clear clinical development strategy,” said Dominik Escher. “We believe these programs have the potential to bring much better treatment options to patients. We are excited to lead this financing and support Tavo through its next phase of growth.”

The new capital will support ongoing clinical and preclinical development activities for TAV-001 and TAV-002, as well as expand Tavo’s research capabilities as the company progresses toward key clinical milestones.

About Tavo Biotherapeutics
Tavo Biotherapeutics is focused on developing novel therapeutics aimed at addressing significant unmet medical needs in ophthalmology, with a particular emphasis on preserving vision and improving long-term outcomes for patients with glaucoma and retinal disease.

TAV-001 is being studied as a potential disease-modifying topical therapy for the treatment of glaucoma. TAV-001 utilizes a dual mode of action that targets the autonomic nervous system, which drives the mechanisms that cause inflammation and degeneration in glaucoma. The program is moving into a Phase 2 clinical trial in the second half of 2026.

TAV-002 is a bispecific antibody that targets both VEGF and a protein involved in upstream signaling in serious retinal diseases, including both wet and dry forms of age-related macular degeneration as well as diabetes-related retinopathies.

Media Contact:
Graham Cooper
[email protected]

SOURCE Tavo Biotherapeutics

With more than $1B in secured business, the funding accelerates inventory build-out to meet the rising demand for open, multi-vendor, and Heterogeneous AI infrastructure

RA’ANANA, Israel, June 1, 2026 — DriveNets, a leader in large-scale networking solutions, today announced it has completed a $410 million Series D financing round, reaching $1 billion total capital raised. With more than $1B in secured business and having been cash-flow positive since 2025, the company will use the additional funding to scale inventory to support its growing AI fabric pipeline and expand its Heterogeneous AI infrastructure solutions. The funding round was led by Bessemer Venture Partners and Atreides Management. New investors, AMD and Red Dot Capital, joined alongside existing investors Pitango and D1 Capital Partners.

Since the company’s founding ten years ago, DriveNets’ Network Cloud has become the network of record for the world’s largest telecommunications companies. Built on the same engineering foundation, DriveNets’ Ethernet-based AI fabric supports large-scale AI infrastructures built by foundation labs, hyperscalers, NeoClouds, and large enterprises. The company is now working with leading AI vendors such as AMD, Broadcom, and others to tighten the integration between networking and compute in multi-vendor AI environments, maximizing cluster performance and GPU utilization to substantially improve token economics. It is also partnering with Dell, Supermicro, and other systems partners on go-to-market activities.

“This financing round marks a pivotal step in scaling our company to meet the surging demand for large-scale AI infrastructure,” said Ido Susan, CEO and Co-Founder of DriveNets. “The most expensive idle asset in the world right now is a GPU waiting on the network. We’re applying a decade of high-performance networking expertise to enable our customers to achieve higher utilization, reduce cost per workload, and scale their AI operations efficiently — on any AI accelerator they choose.”

“AI infrastructure is entering a new era of open, integrated systems where compute, networking, and software scale together,” said Vamsi Boppana, senior vice president of AI at AMD. “Our support of DriveNets’ Series D reflects a shared commitment to scaling AI workloads efficiently with AMD Instinct accelerators and DriveNets’ high-performance fabric on open infrastructure, advancing open, standards-based AI data centers.”

Addressing the most expensive idle asset problem – a GPU waiting on the network

DriveNets’ AI fabric solutions are based on standard Ethernet and support scale-up, scale-out, and scale-across architectures, along with front-end and storage connectivity for large-scale AI clusters.  They address two fundamental constraints in AI infrastructures today: large GPU clusters operating below peak efficiency due to network bottlenecks and reliability challenges, and slow cluster bring-up time (‘idle Capex’), especially in multi-vendor environments.

DriveNets’ high-performance AI Fabric eliminates networking bottlenecks by performing end-to-end networking optimizations across the entire AI stack, including collective communication libraries, transport protocols, NICs, the network fabric, and system-level orchestration. Some of these optimizations are developed in collaboration with leading AI accelerator vendors, such as the recently published validated reference architecture for AMD-DriveNets-based clusters that maximizes GPU utilization, reduces cost-per-token, and enables rapid deployment and efficient end-to-end scaling.

“As AI systems reach unprecedented scale, the performance of the underlying network fabric has become a primary driver of AI economics,” said Charlie Kawwas, President, Semiconductor Solutions Group, Broadcom. “Broadcom’s AI semiconductor and Ethernet switching solutions, combined with DriveNets’ high-performance fabric, deliver the scale and efficiency that modern AI workloads demand. This collaboration reflects how open Ethernet is becoming the foundation of the next-generation AI data center.”

“AI networking is on track to surpass $200 billion by the end of the decade, driven by the shift from single-vendor stacks to multi-vendor and later heterogeneous AI infrastructures. DriveNets enters this phase with a strong combination — tier-one service provider reliability, validated AMD reference design, and the inventory position to deliver into a supply-constrained market. That positions the company well as open Ethernet becomes the foundation of next-generation AI infrastructure,” said Alan Weckel, Founder and Technology Analyst, 650 Group.

DriveNets – a foundational player in Heterogeneous AI

The recent AI infrastructure spending shift from training to inference is expected to drive the adoption of Heterogeneous AI architectures that bring infrastructure costs down and optimize power utilization.

Heterogeneous AI architecture uses multiple AI accelerators from multiple vendors within the same cluster, each best for a different stage or task within the AI training or inference process. The compute resources in the cluster are orchestrated to provide the best overall performance and power utilization, to reduce cost per million tokens and maximize tokens per watt.

DriveNets’ AI fabric is uniquely positioned to support Heterogeneous multi-vendor AI environments due to its ability to perform full-stack optimization for any AI accelerator in the cluster, maximizing the performance and utilization of the entire cluster.

“Every shift in compute produces a new networking giant. Cisco wired the internet. Arista wired the cloud. NVIDIA wired single-vendor AI. DriveNets is wiring what comes next: Heterogeneous AI,” said Adam Fisher, Partner, Bessemer Venture Partners. “This is why BVP led DriveNets’ $410M Series D, an existing portfolio company we’ve backed since its Series A.”

About DriveNets

DriveNets is a leader in large-scale networking solutions for AI infrastructure and service providers. The company’s disaggregated networking architecture transforms the economics of large-scale infrastructures while maximizing performance, utilization, and operational efficiency. Its high-performance AI fabric maximizes GPU utilization and accelerates deployments by optimizing the AI stack end-to-end, resulting in higher tokens-per-second and lower cost-per-token. DriveNets’ solutions power production networks for global tier-1 operators like AT&T and Comcast, and scale multi-vendor AI infrastructures at foundation model labs, NeoClouds, and enterprises. Learn more at https://www.drivenets.com

Logo – https://mma.prnewswire.com/media/1657406/5997029/DriveNets_Logo.jpg

HashKey Capital leads the Series B1 round, with follow-on participation from BlockBooster and AppWorks. GS served as sole financial advisor.

HONG KONG, June 1, 2026 — SignalPlus, a leading provider of institutional digital assets options and derivatives trading infrastructure, today announced the closing of its US$50M Series B1 funding round at a post-money valuation of US$500M. This round was led by HashKey Capital, with follow-on participation from BlockBooster and AppWorks. This investment reflects institutional conviction in SignalPlus’s evolution from a digital assets specialist into an institutional-grade, multi-asset trading infrastructure provider.

Goldman Sachs served as the sole financial advisor on the transaction.

Empowering Institutional Options & Derivatives Trading with Best-in-Class Technology

Founded by a team of capital markets veterans and enterprise tech builders, SignalPlus has established a reputation as the industry-leading options trading platform for institutional traders in the digital assets space. The company’s flagship trading terminal offers a Wall Street-grade position and order execution management system made accessible to the professional trader. Featuring multi-venue connectivity to the industry’s largest exchanges, it delivers unparalleled risk attribution, position analytics, and comprehensive ‘what-if’ scenario analysis exceeding the standard of current market alternatives.

Additionally, its comprehensive risk management and pricing infrastructure enables professional clients and centralized exchanges to operate automated risk management and structured product pricing around the clock. Trusted by the industry’s largest market makers and CEXs, the company achieved a record US$160 billion in platform volumes during Q4-2025, including nearly US$70 billion in Block-RFQ transactions cleared via Deribit alone. Furthermore, terminal volumes have grown at a 74% quarterly CAGR since 2023, driven by a significant rise in institutional onboarding, with the SignalPlus platform now servicing the industry’s largest options players including Cumberland, FalconX, and Galaxy Digital.

Bridging the Technology Gap Between Digital Assets & Traditional Finance

As the institutional adoption of digital assets accelerates, SignalPlus has expanded its technology suite to support structured commodity products, bringing vital modernization to a market long reliant on outdated legacy infrastructure. Proceeds from this latest fundraising round will drive product diversification and geographic expansion, building upon a trajectory that has seen the company’s market share multiply tenfold over the past 18 months.

Furthermore, SignalPlus will be releasing a comprehensive platform upgrade integrating agentic AI into its existing product workflow. Powered by the company’s proprietary QuantLab engine, users will soon be able to analyze volatility market structure, perform strategy back-testing, and create actionable trading modules — a step-change improvement over the workflow available at incumbent brokerages.

“SignalPlus was founded with the ambitious goal to be the leading infrastructure bridge connecting digital assets with traditional capital markets, a journey defined by strict operational discipline at every cycle. This funding round powers the next inflection point – growing our crypto leadership against a maturing regulatory backdrop, extending our institutional-grade infrastructure into traditional finance, and launching the SignalPlus 2.0 platform to bring agentic AI capabilities into a secure trading environment accessible to every user,” said Chris Yu, Co-Founder and CEO of SignalPlus.

“The digital asset market is entering a new phase of institutional maturity, and SignalPlus has established itself as the leading infrastructure provider in the crypto options space, delivering a platform that meets the highest standards of operational rigor, risk management, and liquidity demanded by top-tier institutions globally. We believe the next wave of digital finance will win at the infrastructure layer, and in options, SignalPlus is already defining that standard. As regulatory clarity accelerates across key markets, this partnership will be central to expanding HashKey Group’s product offerings and reinforcing our leadership across the institutional digital asset ecosystem. We are pleased to lead this round and to deepen our long-term partnership with the team,” said Deng Chao, CEO of HashKey Capital.

“SignalPlus provides the infrastructure underpinning institutional participation in digital asset derivatives, combining the liquidity, risk management, and operational rigor that sophisticated players demand. Our relationship with the team long predates this round, and this investment directly aligns with a core thesis BlockBooster has long held: that institutional capital will enter digital assets through credible, enterprise-grade infrastructure. As a full-stack alternative asset manager pairing an incubation engine with capital management, we see SignalPlus sitting precisely at that intersection. We anticipate deep collaboration as their infrastructure connects with our capital strategies and broader ecosystem, and we are proud to back that vision with a significant commitment as the team enters its next phase of growth,” said Samuel Gu, Founder and CEO of BlockBooster.

About SignalPlus

Headquartered in Hong Kong, SignalPlus builds institutional-grade derivatives trading infrastructure for the converging capital markets. Its platform provides professional options analytics, real-time risk management, and execution tools to hedge funds, market makers, proprietary trading desks, and asset managers across digital and traditional financial markets. The company partners with the industry’s leading exchanges and trading institutions, and is backed by HashKey Capital, AppWorks, Tencent, and other prominent technology and financial investors.

Media Contact

Corri Wang
+65 88107289
[email protected]
www.signalplus.com

SOURCE SignalPlus

Growth capital will fund new CardsHQ stores in major U.S. markets, increased investment in the Market Movers data platform, and deeper integration of content, commerce, live breaking, and community for trading card collectors.

ATLANTA, June 1, 2026 — CardsHQ and Sports Card Investor, today announced a strategic growth investment led by Shamrock Capital, a Los-Angeles based investment firm specializing in the media, entertainment, communications, sports, marketing, and technology services sectors alongside EnOne Ventures, a new early- to growth-stage investment platform co-founded by OneTeam Partners and EnTrust Global. The investment merges CardsHQ and Sports Card Investor into a single company operating together as CardsHQ, creating the largest commerce, media and technology platform in the sports card and trading card game (“TCG”) ecosystem.

The investment will accelerate CardsHQ’s national retail expansion strategy, advance the development of its collector-facing technology platform, and create new ways for collectors and fans to engage with the hobby and community. The combined company will serve as a scaled, well-capitalized, and trusted retail and distribution partner at a pivotal moment for the category, as the hobby market continues to evolve across physical retail, live events, digital media, and data-driven experiences.

Growth initiatives include opening additional retail locations, expanding breaking and e-commerce experience, hosting more live events, and significantly broadening inventory selection. CardsHQ’s next retail location is expected to open later this year, with additional flagship locations planned in major markets across the U.S.

The investment will also support the continued growth of Sports Card Investor’s digital media platform, including expanded sports card and TCG content across YouTube and social media. In addition, the company plans to further enhance the Market Movers data platform, which hobbyists use to research, value, and track their card collections.

Founded by entrepreneur and lifelong collector Geoff Wilson and co-founded with Carter Musgrave, the original CardsHQ flagship in Atlanta established a new standard for modern hobby retail by combining expansive inventory, live breaking, events, and e-commerce in a single trusted destination for collectors. Wilson will serve as CEO of the newly formed CardsHQ.

“Everything we do at CardsHQ and Sports Card Investor starts with the community,” said Wilson. “This investment lets us bring the CardsHQ experience to more cities, build better tools for collectors to research and value their cards, and create more ways for athletes, fans, and the broader hobby community to come together. The trading card industry is one of the most vibrant consumer categories in the country right now, and this partnership lets us serve it at a much bigger scale.”

Wilson added: “Shamrock and EnOne bring deep expertise across media, sports, licensing, and technology — exactly the partners we need for this next phase. EnOne’s connection with the players associations will also open new opportunities to engage athletes directly with the collector community, which is something we know our customers care deeply about.”

“We’re excited about the collectibles market, growth of the communities across sports and other card categories and partnering with CardsHQ, which has built a market leading platform in this category,” said Ryan Smiley and Sam Halls, Partners at Shamrock Capital. “The combination of media reach, data products, experiential retail, and commerce infrastructure creates a highly differentiated flywheel that’s well suited to serve these passionate communities and drive growth going forward.”

“Sports cards are one of the most authentic ways athletes connect with fans, and that connection has never been more important,” said Frank Arthofer, President at OneTeam Partners and Investment Committee Member at EnOne Ventures. “CardsHQ has built the platform, the audience, and the retail presence to make those connections meaningful at scale. Through EnOne’s relationships with the players associations, we’re excited to help bring athletes closer to the collector community in new ways.”

The investment in CardsHQ reflects growing institutional interest in the continued growth and evolution of the trading card market — a category increasingly defined by experiential retail, live and social commerce, analytics platforms, and a more connected relationship among athletes, collectors, and content.

About CardsHQ

CardsHQ is a collector-first sports and trading card company that elevates the collector experience through compelling content, insightful apps, engaging commerce, a thriving community, and an incredible selection of fairly priced products. CardsHQ operates across retail, e-commerce, breaking, live selling, content, data and technology, including the Sports Card Investor content network and the Market Movers pricing and collection tracking platform. The company is headquartered in Atlanta, Georgia. For more information, visit Cardshq.com and SportsCardInvestor.com.

About Shamrock Capital

Shamrock Capital is a Los Angeles-based investment firm specializing in media, entertainment, content, communications, sports, marketing, education and technology services. Shamrock invests through a multi-fund strategy centered on private equity investments, as well as ownership and financing of content and media rights. Originally founded in 1978 as the family investment company for the late Roy E. Disney, Shamrock has evolved into an institutionally backed firm with approximately $7.4 billion of assets under management as of May 8, 2026. Shamrock Capital partners with strong management teams and takes an active, collaborative approach to creating value in each investment. For more information, visit www.shamrockcap.com.

About EnOne Ventures

EnOne Ventures (EnOne) is a collaboration between EnTrust Global’s over $17 billion global investment platform with nearly three decades of opportunistic investing, and OneTeam Partners, the leading athlete-driven commercial platform that manages and monetizes proprietary intellectual property on behalf of professional players associations and tens of thousands of professional and collegiate athletes.  This new fund partnership represents a differentiated market position, access, and suite of capabilities for investing in the sports, media, and entertainment ecosystem.  As an early- to growth-stage fund, EnOne targets companies where athletes and their IP play a central role in value creation across areas such as consumer products, technology, health and wellness, and youth sports.  For more information, visit www.enoneventures.com.

Media Contact

Kelly Bell
EVP, Media and Marketing
[email protected]
(404) 590-1665

SOURCE CardsHQ

Sports technology startup raises seed round led by Parlay Capital to build the real-time market engine that turns live game moments into tradable markets

NEW YORK, June 1, 2026 — SpeedLabs, the real-time market engine for sports, today announced a $6.5 million seed round led by Parlay Capital, with participation from Bullpen Capital, TA Ventures, EdgeEquity, and additional investors with deep experience across sports, gaming, and consumer technology. The company will use the funding to scale its team as they launch Momentum Markets in summer 2026.

Momentum Markets are designed to capture the moments fans actually care about – the injury that swings a game, the run that flips the score, the big play that changes everything. A sportsbook’s answer to a momentum swing is a new price on an old market. SpeedLabs’ answer is a new market entirely – created in response to what just happened and priced instantly, instead of an outcome a sportsbook decided to offer hours earlier.

SpeedLabs is building the first market layer designed for what is actually happening on the field. Powered by foundation models purpose-built for sports, the SpeedLabs engine reads the flow of a live game, then creates and prices new markets instantly. The result: live, in-game markets that let fans take a side on whether the game’s momentum continues.

The category is already proving itself in adjacent verticals. On Polymarket, five-minute Bitcoin price markets have generated more than $4 billion in total trading volume, with $153 million in a single day. The lesson, according to SpeedLabs, is that short-duration markets capture demand no existing instrument has captured before. Sports is already the dominant category on US prediction markets, accounting for roughly 90% of activity on Kalshi. SpeedLabs is building the engine to power what comes next.

“Sports betting is getting lapped,” said Nick Meader, CEO of SpeedLabs. “Prediction markets are minting new categories every week. Meanwhile sportsbooks are stuck on the same pre-set markets and bet types. The market for trading on what is happening right now is enormous, and sports – the most-watched, most-discussed, most-emotional category on the planet – is the one place where you still can’t really do it. SpeedLabs is building the engine that fixes that.”

“SpeedLabs is doing something we have not seen before: using AI to create the market itself, not just price markets that already exist,” said Greg Buonocore, CEO and Managing Partner at Parlay Capital Holdings. “Every other company in this space is building incremental improvements to a category that has been structurally unchanged for decades. Nick and the SpeedLabs team are building the layer that the next generation of sportsbooks and prediction markets will run on. We are thrilled to lead this round.”

The $6.5 million round will fund SpeedLabs’ build-out ahead of its summer 2026 launch. The company is hiring across C-level leadership, engineering, machine learning, trading and sports betting expertise, and growth.

About SpeedLabs

SpeedLabs is the real-time market engine for sports, pioneering Momentum Markets – live, in-game markets that let fans take a side on whether the game’s momentum continues. Built on foundation models purpose-built for sports, SpeedLabs reads the flow of a game, then creates and prices new markets in seconds, replacing the pre-set offerings the rest of the industry still relies on. SpeedLabs partners with sportsbooks, prediction markets, and the platforms where fans trade on sports. Learn more at speedlabs.dev

SOURCE SpeedLabs

COSTA MESA, Calif., June 1, 2026 — Veritas Aortic Solutions, the latest company to spin out of inQB8 Medical Technologies, is pleased to announce the closing of $12M in Seed financing to advance innovative solutions for the treatment of Root and Ascending Aortic Diseases. The funding round was led by a group of experienced MedTech angel investors with strong participation from Cedars-Sinai Intellectual Property Company along with inQB8’s existing investors. The funds will support the continued development of the Veritas Transcatheter Valved Aortic Root Conduit (TVARC) through First-in-Human clinical use. The Veritas TVARC is designed to offer a comprehensive, interventional, non-surgical treatment for high-risk Root and Ascending Aortic Diseases, including Dissections, Aneurysms, and other pathologies that specifically involve the aortic root, coronary ostia, and/or the ascending aorta.

As part of the financing, Chad Martinson (former Medtronic CoreValve executive and former CEO of ACOVA Integrated Health), Judd Nordquist (CEO of Ibis Scientific), and Nirdesh Gupta PhD (Managing Partner of Cedars-Sinai Intellectual Property Company (CSIPCo)), joined Veritas and inQB8 co-founders, Arshad Quadri, MD and J. Brent Ratz, on the company’s Board of Directors.

“With combined mortality and morbidity rates as high as 65%, it is hard to overstate the risk associated with current surgical treatments for acute conditions of the ascending aorta,” said Arshad Quadri MD, Co-Founder, Executive Chairman and Chief Medical Officer of Veritas Aortic Solutions. “As a cardiac surgeon myself, I have performed these procedures numerous times. They are complex, challenging, and highly invasive. Endovascular options for the descending aorta and the arch have been available for a long time, but open-heart surgery remains the only approved option for patients with root and ascending aortic pathologies. It has always been a dream of mine to be able to offer these patients a faster, safer, less-invasive option, and today we are one step closer to making that a reality.”

The Veritas TVARC system is a single permanent implant that combines a bioprosthetic aortic valve, ascending aortic graft, and the company’s proprietary Chameleon Eye™ coronary perfusion ports and is designed to seal-off the diseased or damaged part of the aorta and restore healthy blood flow to the coronaries and the rest of the body. The system includes a custom transfemoral delivery catheter that is intended to eliminate the need for open-heart surgery and allow for precise positioning and controlled deployment of the implant.

“The Veritas TVARC system represents the type of patient-centered innovation we seek to support at Cedars-Sinai,” said Nirdesh Gupta, PhD, Managing Partner of Cedars-Sinai Intellectual Property Company. “We are pleased to participate in this financing to help advance a novel endovascular approach to Aortic Root and Ascending Aortic Disease—an area where treatment options have remained largely unchanged for years despite significant patient risk. We believe this technology has the potential to meaningfully improve outcomes for patients facing life-threatening cardiovascular disease.”

“After establishing the Veritas program within inQB8 Medical Technologies and rapidly advancing it through prototyping, bench testing, and successful chronic animal studies, we are honored to have the support of seasoned MedTech investors, leading physicians, and a world-class healthcare organization like Cedars-Sinai to accelerate our development and bring this technology towards its first clinical application,” added J. Brent Ratz, Co-Founder and Chief Executive Officer of Veritas Aortic Solutions. “In our 20+ year partnership, Dr. Quadri and I have collaborated to create solutions for several cardiovascular issues. Given the complexity of Root and Ascending Aortic Diseases and the dire need for an interventional solution, I believe Veritas is poised to be the most meaningful of all in terms of patient impact.”

About Veritas Aortic Solutions
Veritas Aortic Solutions is a privately held medical device company committed to improving outcomes for patients with Aortic Disease. The company’s flagship technology, the Veritas Transcatheter Valved Aortic Root Conduit (TVARC) is a single permanent implant that combines a bioprosthetic aortic valve, ascending aortic graft, and the company’s proprietary Chameleon Eye™ coronary perfusion ports and is designed to seal-off the diseased or damaged part of the aorta and restore healthy blood flow to the coronaries and the rest of the body. Veritas was founded and incubated within inQB8 Medical Technologies, LLC and spun-out as a standalone company in late 2025 to provide a comprehensive solution to pathologies affecting the most critical areas of the heart, including the aortic root, coronaries and ascending aorta. www.veritasaortic.com

About Cedars-Sinai Intellectual Property Company (CSIPCo)
Cedars-Sinai Intellectual Property Company is the investment arm of Cedars-Sinai, focused on healthcare and life sciences startups across med tech (devices & diagnostics), biotech (drug discovery programs) and health tech (regulated digital health). CSIPCo invests in companies that strongly align with Cedars-Sinai Health System’s mission of advancing healthcare and improving patient outcomes.

About inQB8 Medical Technologies LLC
inQB8 Medical Technologies is a privately held medical device incubator with offices in Massachusetts and California co-founded by Dr. Arshad Quadri, MD, and J. Brent Ratz, MBA. inQB8 specializes in developing cutting-edge interventional solutions for major cardiovascular diseases, accelerating projects through prototyping, bench, and pre-clinical testing. Veritas is the fourth program to come out of the inQB8 team. Previous successes include CardiAQ Valve Technologies (Transcatheter Mitral Valve Replacement, acquired by Edwards Lifesciences in 2015), MonarQ (Transcatheter Tricuspid Valve Replacement, acquired by Peijia Medical in 2021), and Relief Cardiovascular (interventional Heart Failure management, formed in 2024 with Series A and FIH completed in 2025).

SOURCE Veritas Aortic Solutions

The Richmond office opens June 1, followed by a Chesapeake office July 1. Together, the locations establish Insurcomm’s footprint in Virginia and extend its 24/7 emergency response across both the Richmond metro and Hampton Roads. Customers can rely on Insurcomm for emergency response, remediation, reconstruction, and environmental services—all handled by one team that sees the job from start to finish.

“Virginia property owners and the carriers who serve them deserve a team they can count on when things don’t go as planned,” said Kelly Brewer, CEO of Insurcomm Restoration and Fortify Companies. “Opening in Richmond and Chesapeake lets us be closer, respond faster, and deliver the full set of capabilities people need—whether it’s a single property loss or a larger, more complex event. That’s what everything going right looks like.” 

Strengthening Regional Response and Support

Virginia properties face year-round risk, from Atlantic hurricanes and coastal storms to water intrusion, fire and smoke damage, and mold. With local teams now on the ground backed by national resources, Insurcomm can respond quickly, manage every stage of recovery under one roof, and maintain consistent service across the region when demand surges. Clients work with a single accountable team and a single point of contact from first notice of loss through final walkthrough, eliminating the handoffs and delays that characterize a typical restoration claim.

A Growing National Network

The Virginia offices are part of a broader, coordinated network built through Fortify Companies, bringing together local response capabilities with national scale. As part of the Fortify platform, Insurcomm connects prevention, emergency response, and reconstruction under one roof—helping reduce delays, improve visibility, and deliver a more seamless recovery experience from initial loss through long-term property care.

Need Emergency Restoration in Virginia?

For more information or to request emergency service, visit www.insurcomm.com or call (844) 424-9283.

About Insurcomm

Insurcomm delivers full-service restoration and emergency response you can count on when everything needs to go right across residential, commercial, and catastrophe response. For more than 30 years, we’ve helped property owners, facility teams, and communities recover from water, fire, mold, storm events, and environmental hazards.

We believe people deserve to know what’s happening, who’s handling it, and when it will be done, without surprises and without delays. From the first call to the final walkthrough, our mission is simple: You deserve everything going right, so we built a company that makes it happen.

To learn more about Insurcomm, visit our website or follow us on LinkedIn, Facebook, or Instagram.

About Fortify Companies 

Fortify Companies is building the nation’s most trusted property protection platform by uniting exceptional local teams across restoration, property services, and loss prevention under one operating standard. Faster response. Better outcomes. More resilient properties and communities. Learn more at fortifycompanies.com.

SOURCE Insurcomm Restoration